Skip to main content
Winner Medical Co., Ltd. logo

Winner Medical Co., Ltd. — Investor Relations & Filings

Ticker · 300888 ISIN · CNE1000047Z8 LEI · 3003001HWYP0KVG4J717 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 737 across all filing types
Latest filing 2026-04-21 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 300888

About Winner Medical Co., Ltd.

https://www.winnermedical.com

Winner Medical Co., Ltd. specializes in the research, development, manufacturing, and distribution of cotton-based medical dressings and consumer health products. The company operates through two primary segments: medical supplies and consumer goods. Its medical portfolio includes high-quality wound care products, surgical kits, and infection prevention supplies such as masks and protective gowns. Under its PurCotton brand, the company produces a wide range of consumer items, including cotton tissues, feminine care products, and baby care essentials, utilizing proprietary non-woven cotton technology. Winner Medical emphasizes the use of natural materials to provide safe, comfortable, and environmentally friendly solutions. The company maintains a vertically integrated supply chain and adheres to international quality standards, serving healthcare institutions and retail markets worldwide with a focus on hygiene and skin-friendly applications.

Recent filings

Filing Released Lang Actions
2026年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2026 年第一季度报告" which translates to "2026 First Quarter Report." It contains detailed financial data including consolidated balance sheets, profit and loss statements, cash flow statements, and extensive financial metrics for the first quarter of 2026. The document includes actual financial figures, comparisons with prior periods, and management commentary on business segments and operations. The length is substantial (15,000 characters), and it is not merely an announcement or a certification. The content matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing substantive financial data and analysis. Q1 2026
2026-04-21 Chinese
2025年年度审计报告
Regulatory Filings
2026-04-21 Chinese
关于完成工商变更登记的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the completion of industrial and commercial registration changes and amendments to the company's articles of association. It mentions board meetings and shareholder meetings approving these changes, and the completion of registration with the Shenzhen Market Supervision Bureau. The document is short (531 characters) and serves as a formal notification of corporate governance changes and registration completion, not a detailed report or financial statement. It does not contain financial data or detailed management discussion. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes in the company's board or management and related corporate governance updates.
2025-11-17 Chinese
关于参加2025年度深圳辖区上市公司投资者网上集体接待日活动的公告
Regulatory Filings Classification · 95% confidence The document is an announcement about the company's participation in an online investor interaction event organized by regulatory and investor service bodies. It mentions the date and format of the event and invites investors to participate. There is no financial data, no detailed report, no voting results, no management changes, or other specific filings. The document is short (563 characters) and serves as a public notice of an upcoming investor event rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2025-11-14 Chinese
关于向2024年限制性股票激励计划激励对象授予预留限制性股票的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the granting of reserved restricted shares under a 2024 restricted stock incentive plan by the company. It details the approval process, grant conditions, number of shares, pricing, vesting arrangements, performance targets, and legal opinions. It is not a full financial report or earnings release but a specific announcement about a share-based incentive plan grant to employees and management. This fits the category of Capital/Financing Update (CAP) because it relates to changes in the company's capital structure through share grants under an incentive plan. The document length is sufficient and contains detailed information about the share grant, not just a brief notice or a report publication announcement. Therefore, the appropriate classification is CAP with high confidence.
2025-11-12 Chinese
董事会薪酬与考核委员会关于2024年限制性股票激励计划预留授予激励对象名单的核查意见
Remuneration Information Classification · 95% confidence The document is a formal opinion from the company's Board Remuneration and Assessment Committee regarding the verification of the reserved grant list for a 2024 restricted stock incentive plan. It references compliance with company law, securities law, stock exchange listing rules, and internal company regulations. The content focuses on approval and compliance of a stock incentive plan, including details on the grant date, price, and number of shares. This type of document is related to remuneration and compensation information for executives and directors rather than a full annual report, earnings release, or other financial report. Therefore, it fits best under the Remuneration Information category (DEF 14A). The document length is short and specific to remuneration matters, not a general regulatory filing or announcement of a report.
2025-11-12 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.